Two-thirds of Americans say the abortion drug mifepristone, used in the majority of abortions in the United States, should remain on the market, according to a Washington Post-ABC News poll.

The poll finds that 66 percent of U.S. adults say mifepristone should remain on the market, while 24 percent say it should be taken off the market. Just under half, 47 percent, say access to mifepristone should be kept as is; 12 percent say it should remain on the market but be more restricted than it is now.

The drug is at the center of an escalating legal dispute. The Supreme Court of the United States (SCOTUS) preserved full access to mifepristone in April, putting on hold a lower court’s ruling that the Food and Drug Administration (FDA) erred in making the drug more broadly available. This month, the U.S. Court of Appeals for the 5^th Circuit will consider the case brought by antiabortion groups against the FDA’s regulation of mifepristone, a decision that will almost surely be appealed to SCOTUS.

Please select this link to read the complete article from The Washington Post.